J Neurogastroenterol Motil  
The Effect of Trimebutine and/or Helicobacter pylori Eradication on the Gastroesophageal Reflux Disease, Irritable Bowel Syndrome and Functional Dyspepsia Overlapping Disorders
Jannis Kountouras1*, Emmanuel Gavalas1, Michael Doulberis1, 2, Stergios A. Polyzos1, 3, Apostolis Papaefthimiou1, 4, Maria Touloumtsi1, Elisabeth Vardaka1, Konstantinos Kountouras1, Katerina Papanikolopoulou1, Panagiotis Katsinelos1
1Department of Medicine, Second Medical Clinic, Aristotle University of Thessaloniki, Ippokration Hospital, Thessaloniki, Macedonia, Greece, 2Department of General Internal Medicine, University Hospital Inselspital, Bern 3010, Switzerland, 3First Department of Pharmacology, Department of Medicine, Aristotle University of Thessaloniki, Ippokration Hospital, Thessaloniki, Macedonia, Greece, 4Department of Gastroenterology, 401 General Military Hospital of Athens, Athens 11525, Greece
Received: January 21, 2019; Accepted: April 11, 2019; Published online: May 15, 2019.
© The Korean Society of Neurogastroenterology and Motility. All rights reserved.



This Article

e-submission

Archives

Aims and Scope